4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-067758
Interim CEO & General Counsel bought 1,000 shares at $6.44 ($6,440)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2022-06-01 | Purchase | +1,000 | $6.44 | $6,440 | 1,000 | D: show line 1 in the form |
| Open-market purchases · 1,000 sh · avg $6.44 · $6,440 | |||||||
Loading xslF345X03/tm2217576d2_4seq1.xml…